Onderzoeker
Pascal VRANCKX
- Trefwoorden:Biomedische wetenschappen, Geneeskunde
- Disciplines:Cardiologie, Vasculaire ziekten, Spoedgevallen, Medisch intensieve zorgen, Chirurgische intensieve zorgen, Biofarmaceutica, Farmacodynamica, Farmacokinetica, Farmacologie niet elders geclassificeerd
Affiliaties
- Cardio & orgaansystemen (Departement)
Lid
Vanaf1 jan 2020 → Heden - Cardio & orgaansystemen (Onderzoeksgroep)
Lid
Vanaf1 jan 2020 → Heden - Limburg Clinical Research Center (Onderzoekscentrum)
Lid
Vanaf1 jan 2020 → Heden - Geneeskunde en Levenswetenschappen (Faculteit)
Lid
Vanaf1 okt 2017 → Heden - Health Care (Onderzoeksgroep)
Lid
Vanaf16 mrt 2019 → 31 dec 2019 - Fysiologie - biochemie - immunologie (Departement)
Lid
Vanaf1 okt 2017 → 31 dec 2019
Publicaties
11 - 20 van 134
- Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week(2023)
Auteurs: Johan VERBEECK, Mickael De Backer, Jan VERWERFT, Samuel Salvaggio, Marco Valgimigli, Pascal VRANCKX, Marc BUYSE, Edgar Brunner
Pagina's: 1360 - 1372 - 1-or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI(2023)
Auteurs: Marco Valgimigli, Alessandro Spirito, Samantha Sartori, Dominick J. Angiolillo, Pascal VRANCKX, Jose M. de la Torre Hernandez, Mitchell W. Krucoff, Sripal Bangalore, Deepak L. Bhatt, Gianluca Campo, et al.
Pagina's: 2498 - 2510 - Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success A Swiss-Apero Trial Subanalysis(2023)
Auteurs: Roberto Galea, Adel Aminian, Nicolas Meneveau, Federico De Marco, Dik Heg, Frederic Anselme, Christoph Grani, Adrian T. Huber, Emmanuel Teiger, Xavier Iriart, et al.
Pagina's: 1332 - 1343 - Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial(2023)
Auteurs: Jorge Sanz-Sanchez, Hector M. Garcia-Garcia, Mattia Branca, Enrico Frigoli, Sergio Leonardi, Andrea Gagnor, Paolo Calabro, Stefano Garducci, Paolo Rubartelli, Carlo Briguori, et al.
Pagina's: 782 - 791 - Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT(2023)
Auteurs: Alessandro Spirito, Marco Valgimigli, Davide Cao, Usman Baber, Shamir R. Mehta, C. Michael Gibson, Gabriel P. Steg, Samin K. Sharma, Ridhima Goel, Kurt Huber, et al.
Pagina's: 24 - 32 - Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary Syndrome(2023)
Auteurs: Antonio Landi, Mattia Branca, Sergio Leonardi, Enrico Frigoli, Pascal VRANCKX, Matteo Tebaldi, Ferdinando Varbella, Paolo Calabro, Giovanni Esposito, Gennaro Sardella, et al.
Pagina's: 193 - 205 - Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium(2023)
Auteurs: Davide Capodanno, Roxana Mehran, Mitchell W. Krucoff, Usman Baber, Deepak L. Bhatt, Piera Capranzano, Jean-Philippe Collet, Thomas Cuisset, Giuseppe De Luca, Leonardo De Luca, et al.
Pagina's: 1933 - 1944 - Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis(2022)
Auteurs: M Valgimigli, PC Smits, E Frigoli, D Bongiovanni, J Tijssen, T Hovasse, A Mafragi, WT Ruifrok, D Karageorgiev, A Aminian, et al.
Pagina's: 3100 - 3114 - Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock JACC Review Topic of the Week(2022)
Auteurs: Christophe Vandenbriele, Deepa J. Arachchillage, Pascal Frederiks, Gennaro Giustino, Diana A. Gorog, Mario Gramegna, Stefan Janssens, Bart Meyns, Amin Polzin, Mara Scandroglio, et al.
Pagina's: 1949 - 1962 - Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials(2022)
Auteurs: Francesco Costa, Claudio Montalto, Mattia Branca, Sung-Jin Hong, Hirotoshi Watanabe, Anna Franzone, Pascal VRANCKX, Joo-Yong Hahn, Hyeon-Cheol Gwon, Fausto Feres, et al.
Pagina's: 954 - 968